SecBot SecBot
6-K ·Filed Sep 24, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed1mo ago SEC0001654954-26-008553
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine plan-related acquisition of a trivial number of shares by a senior executive. It carries no trading signal. Monitor upcoming quarterly results for fundamental performance.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+20d
GSK ▲ +3.14% at T+20d
NEUTRAL call +3.14% · α vs SPY +3.56% · entry $49.65 → $51.21
Next anchor: T+60d in 7w
Latest observation: T+25 -0.95% FF3 residual α
Entry = T+0 close
Sep 24, 2026
via day close
T+1d
-0.83%
call -0.83% · α -1.37%
$49.24
settled 5w ago
T+5d
-4.97%
call -4.97% · α -4.56%
$47.18
settled 29d ago
T+20d
+3.14%
call +3.14% · α +3.56%
$51.21
settled 8d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

GSK filed a routine 6-K disclosing that Maya Martinez-Davis, President US, acquired 9.414 notional ADS at $50.72 within her Executive Supplemental Savings Plan account on September 22, 2026. This is a de minimis plan-related transaction with no material impact on the company's operations or financial position.

Key Facts

  • Maya Martinez-Davis, President US, acquired 9.414 notional ADS at $50.72 per ADS on September 22, 2026.
  • The acquisition was within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account.
  • Total value of the transaction is approximately $477.48.
  • The transaction was executed on the New York Stock Exchange.

Financial Impact

De minimis, approximately $477.48 total value, no impact on GSK's financials.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-008553
Document: 0001654954-26-008553-index-headers.html0001654954-26-008553
Document: 0001654954-26-008553-index.html0001654954-26-008553
Document: 0001654954-26-008553.txt0001654954-26-008553
60 reports for GSK
Performance horizon
47% Hit rate @ T+5 9 of 19 directional calls Went positive at some point 15 of 21 best @ T+60▲ +9.35%Jul 17, 2026
Filters
Rows
Reports for GSK, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
6-K
NEUTRAL ★ 5/10
$48.74awaiting T+5awaiting T+5$48.68 (−0.12%)
Oct 26, 2026
3d ago
6-K
BULLISH ★ 5/10
$51.10awaiting T+5awaiting T+5$48.68 (−4.74%)
Oct 26, 2026
3d ago
6-K
NEUTRAL ★ 1/10
$51.10awaiting T+5awaiting T+5$48.68 (−4.74%)
Oct 26, 2026
4d ago
6-K
BULLISH ★ 5/10
$51.10awaiting T+5awaiting T+5$48.68 (−4.74%)
Oct 26, 2026
4d ago
6-K
NEUTRAL ★ 4/10
$51.10awaiting T+5awaiting T+5$48.68 (−4.74%)
Oct 21, 2026
9d ago
6-K
BULLISH ★ 7/10
$50.02 $50.94▲ +1.84%▲ +2.28%$48.68 (−2.68%)
Oct 19, 2026
10d ago
6-K
BULLISH ★ 7/10
$49.46 $51.10▲ +3.32%▲ +3.46%$48.68 (−1.58%)
Oct 19, 2026
11d ago
6-K
BULLISH ★ 6/10
$49.46 $51.10▲ +3.32%▲ +3.46%$48.68 (−1.58%)
Oct 15, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$49.02 $51.21▲ +4.47%▲ +5.48%$48.68 (−0.69%)
Oct 14, 2026
15d ago
6-K
NEUTRAL ★ 1/10
$47.87 $50.02▲ +4.49%▲ +4.04%$48.68 (+1.69%)
Showing 10 of 60

US Market Status

Market Closed · Opens in 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 24, 2026